After a long, strange trip, this CEO is close to taking a psilocybin pill to market
· businessinsider.com
Compass Pathways is on the cusp of FDA approval for a proprietary version of psilocybin — the active drug in magic mushrooms.
In 2022, Kabir Nath had a cushy executive job at a pharmaceutical firm that developed anti-psychotic medication.
Then he got a call from a scrappy upstart with...